Metraipolis › archive › dc_2bc0c837e8cc

Strategies for robust, accurate, and generalizable benchmarking of drug discovery platforms — Europe PMC PMID:41206130

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41206130
DOI
10.1093/bioinformatics/btaf604
License (as archived)
solo-consultazione
Archived
2026-11-08T21:02:24.506Z
SHA-256 of the archived text
a0b8e11e669d10a02c773762f658d70ac3c7a992a77830d23e86f02a5d22c248
Stable URL of this page
https://metraipolis.com/documento/dc_2bc0c837e8cc

How to cite

Strategies for robust, accurate, and generalizable benchmarking of drug discovery platforms — Europe PMC PMID:41206130 — Europe PMC (en), https://europepmc.org/article/MED/41206130 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2bc0c837e8cc (Metraipolis archive dc_2bc0c837e8cc, sha256 a0b8e11e669d10a02c773762f658d70ac3c7a992a77830d23e86f02a5d22c248)
BibTeX
@misc{dc2bc0c837e8cc,
  title = {Strategies for robust, accurate, and generalizable benchmarking of drug discovery platforms — Europe PMC PMID:41206130},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41206130},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2bc0c837e8cc; sha256 a0b8e11e669d10a02c773762f658d70ac3c7a992a77830d23e86f02a5d22c248},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41206130. Agents can read the archived copy with the MCP tool read_document.